Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock-Reference-Cited by-同舟云学术

Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock

Published:2010-12 Issue:2 Volume:1 Page:147-157
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:J Cachexia Sarcopenia Muscle

Author:

Schefold Joerg C.¹,Bierbrauer Jeffrey²,Weber-Carstens Steffen²

Affiliation:

1. Department of Nephrology and Intensive Care Medicine; Charité University Medicine; Campus Virchow Klinikum, Augustenburger Platz 1 13353 Berlin

2. Department of Anaesthesiology and Operative Intensive Care Medicine; Charité University Medicine; Campus Virchow Klinikum and Campus Charité Mitte Berlin

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

http://www.springerlink.com/index/pdf/10.1007/s13539-010-0010-6

Reference124 articles.

1. Septic shock;Annane;Lancet,2005

2. Current epidemiology of septic shock: the CUB-Réa Network;Annane;Am J Respir Crit Care Med,2003

3. The pathophysiology and treatment of sepsis;Hotchkiss;N Engl J Med,2003

4. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008;Dellinger;Crit Care Med,2008

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of early neuromuscular electrical stimulation in intensive care unit-acquired weakness;Anaesthesia, Pain & Intensive Care;2024-08-09

2. Predictive modeling of ICU-AW inflammatory factors based on machine learning;2024-07-24

3. Risk factors for ICU-acquired weakness in sepsis patients: A retrospective study of 264 patients;Heliyon;2024-06

4. Myostatin gene invalidation does not prevent skeletal muscle mass loss during experimental sepsis in mice;The Journal of Physiology;2024-05-15

5. Protective role of pretreatment with Anisodamine against sepsis-induced diaphragm atrophy via inhibiting JAK2/STAT3 pathway;International Immunopharmacology;2024-05